NCT00499395已完成不适用
Detection of Residual Colorectal Liver Metastases Within 24 Hours After RFA With 18-F FDG PET
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 4
- 试验地点
- 1
- 主要终点
- Sensitivity and specificity of fludeoxyglucose F 18 (FDG)-PET imaging in early diagnosis of residual disease
研究概览
简要总结
RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18-PET imaging, may be effective in detecting residual disease after radiofrequency ablation of liver metastases in patients with colorectal cancer.
PURPOSE: This clinical trial is studying fludeoxyglucose F 18-PET imaging to see how well it works for early detection of residual disease in patients undergoing radiofrequency ablation of liver metastases from colorectal cancer.
详细描述
OBJECTIVES:
Primary
- Determine the sensitivity and specificity of fludeoxyglucose F 18 (FDG)-PET imaging in detecting residual disease within 48 hours after radiofrequency ablation (RFA) of liver metastases in patients with colorectal cancer.
Secondary
- Determine the findings on day 7 after RFA using FDG-PET imaging in these patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •DISEASE CHARACTERISTICS:
- •Diagnosis of colorectal cancer
- •Disease metastatic to the liver
- •Undergoing percutaneous, intraoperative or laparoscopic radiofrequency ablation for liver metastases at the University of North Carolina Gastrointestinal Oncology Clinic
- •PATIENT CHARACTERISTICS:
- •Not pregnant
- •PRIOR CONCURRENT THERAPY:
- •See Disease Characteristics
- •No chemotherapy within 7 days after RFA on study
排除标准
- 未提供
结局指标
主要结局
Sensitivity and specificity of fludeoxyglucose F 18 (FDG)-PET imaging in early diagnosis of residual disease
次要结局
- Findings on day 7 after RFA using FDG-PET imaging
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Fludeoxyglucose F 18 PET Imaging in Determining Protein and Gene Expression Signatures in Patients With Premalignant Polyps or Colon CancerNeoplasm of Uncertain Malignant PotentialColorectal CancerNCT00550628Memorial Sloan Kettering Cancer Center8
尚未招募
不适用
18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic AdenocarcinomaMetastatic Colorectal CancerNCT05531045Assistance Publique - Hôpitaux de Paris222
已完成
不适用
PET and CT Scans in Patients With Locally Advanced Primary Rectal Cancer That Can Be Removed During SurgeryColorectal CancerNCT00004891Memorial Sloan Kettering Cancer Center149
已完成
不适用
Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by SurgeryLung CancerNCT00732563Roswell Park Cancer Institute100
终止
不适用
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing ChemotherapyLung CancerNCT00424138American College of Radiology Imaging Network96